Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients

被引:28
|
作者
Nelson, E. J. R.
Nair, S. C.
Peretz, H.
Coller, B. S.
Seligsohn, U.
Chandy, M.
Srivastava, A. [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Hematol, Vellore 632004, Tamil Nadu, India
[2] Christian Med Coll & Hosp, Dept Clin Pathol, Vellore 632004, Tamil Nadu, India
[3] Tel Aviv Sourasky Med Ctr, Clin Biochem Lab, Tel Aviv, Israel
[4] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA
[5] Chaim Sheba Med Ctr, Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel
关键词
alpha(IIb)beta(3); Glanzmann thrombasthenia; mutations; polymorphisms;
D O I
10.1111/j.1538-7836.2006.02066.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Glanzmann thrombasthenia (GT) is a congenital bleeding disorder caused by either a lack or dysfunction of the platelet integrin alpha(IIb)beta(3). Objectives: To determine the molecular basis of GT in patients from southern India. Patients: Fifteen unrelated patients whose diagnosis was consistent with GT were evaluated. Results: Platelet surface expression of alpha(IIb)beta(3) was < 10%, 10%-50%, and > 50% of controls in five, nine, and one patient(s), respectively. Immunoblotting of the platelet lysates showed no alpha(IIb) in 14 patients, and no beta(3) in 10 patients, although severely reduced in four patients. Platelet fibrinogen was undetectable in 13 patients, and severely reduced in one patient. One patient showed normal surface alpha(IIb)beta(3) expression, and normal alpha(IIb), beta(3) and fibrinogen levels in the lysate. Ten novel candidate disease-causing mutations were identified in 11 patients. The missense mutations included Gly128Ser, Ser287Leu, Gly357Ser, Arg520Trp, Leu799Arg in alpha(IIb), and Cys575Gly in beta(3). We have already shown that Gly128Ser, Ser287Leu, and Gly357Ser mutations variably affect alpha(IIb)beta(3) surface expression. The Cys575Gly mutation may disrupt the disulphide link with Cys586 to cause the GT phenotype. The molecular pathology of the other missense mutations is not clear. Two nonsense mutations, Trp-16Stop and Glu715Stop in alpha(IIb), and a 7-bp deletion (330-336TCCCCAG) in beta(3) are predicted to result in truncated proteins. An IVS15(-1)G -> A mutation in alpha(IIb) induced a cryptic splice site as confirmed by reverse transcription-polymerase chain reaction (RT-PCR) analysis. Thirteen polymorphisms were also identified (five in alpha(IIb) and eight in beta(3)), among which five were novel. Conclusions: While identifying a significant number of novel mutations causing GT, this study confirms the genetic heterogeneity of the disorder in southern India.
引用
收藏
页码:1730 / 1737
页数:8
相关论文
共 44 条
  • [1] Identification of eight novel mutations among ten unrelated Chinese patients with Glanzmann thrombasthenia
    Yu, T.
    Wang, X.
    Ding, Q.
    Dai, J.
    Lu, Y.
    Xi, X.
    Wang, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 889 - 889
  • [2] Novel mutations in Thai patients with glanzmann thrombasthenia
    Ittiwut, Rungnapa
    Suchartlikitwong, Pintip
    Kittikalayawong, Yaowaree
    Ittiwut, Chupong
    Prasopsanti, Karan
    Sosothikul, Darintr
    Shotelersuk, Vorasuk
    Suphapeetiporn, Kanya
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (06) : 520 - 524
  • [3] Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations
    Sandrock-Lang, Kirstin
    Oldenburg, Johannes
    Wiegering, Verena
    Halimeh, Susan
    Santoso, Sentot
    Kurnik, Karin
    Fischer, Lars
    Tsakiris, Dimitrios A.
    Sigl-Kraetzig, Michael
    Brand, Brigitte
    Buehrlen, Martina
    Kraetzer, Katharina
    Deeg, Niklas
    Hund, Martin
    Busse, Eileen
    Kahle, Anja
    Zieger, Barbara
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (04) : 782 - 791
  • [4] Characterization of Patients with Glanzmann Thrombasthenia and Identification of 17 Novel Mutations
    Sandrock-Lang, Kirstin
    Oldenburg, Johannes
    Wiegering, Verena
    Halimeh, Susan
    Santoso, Sentot
    Kurnik, Karin
    Fischer, Lars
    Tsakiris, Dimitrios
    Sigl-Kraetzig, Michael
    Brand, Brigit
    Kraetzer, Katharina
    Deeg, Niklas
    Busse, Eileen
    Barbara, Zieger
    BLOOD, 2014, 124 (21)
  • [5] Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients
    Rosenberg, Nurit
    Dardik, Rima
    Hauschner, Hagit
    Nakav, Sigal
    Barel, Ortal
    Luboshitz, Jacob
    Yacobovich, Joanne
    Tamary, Hannah
    Kenet, Gili
    BLOOD CELLS MOLECULES AND DISEASES, 2021, 89
  • [6] Novel mutations in GP IIb gene in Glanzmann's thrombasthenia from India
    Vijapurkar, Manasi
    Ghosh, Kanjaksha
    Shetty, Shrimati
    PLATELETS, 2009, 20 (01) : 35 - 40
  • [7] Identification of 25 novel mutations in 25 patients with Glanzmann's thrombasthenia
    Yu, Z.
    Cui, Q.
    Su, J.
    Zhao, X.
    Bu, Y.
    Bai, X.
    Ruan, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 342 - 342
  • [8] Identification of four novel mutations in three patients with Glanzmann's Thrombasthenia.
    Bourdon, L
    Cutler, J
    Savidge, GF
    BLOOD, 2005, 106 (11) : 614A - 615A
  • [9] NOVEL MUTATIONS AT GPIIB/GPIIIA GENES FROM TURKISH PATIENTS WITH GLANZMANN THROMBASTHENIA SYNDROME
    Ozkan, D. T.
    Caliskan, U.
    Akar, N.
    HAEMATOLOGICA, 2014, 99 : 467 - 467
  • [10] Structural Analysis of Four Newly Identified Extracellular Membrane-Proximal Missense Mutations in Patients with Glanzmann Thrombasthenia
    Pillois, Xavier
    Fiore, Mathieu
    Nurden, Alan
    BLOOD, 2014, 124 (21)